A sterile, ready-to-use injectable antimicrobial solution that contains enrofloxacin, a broad-spectrum fluoroquinolone
antimicrobial agent. FDA approved for the treatment of bovine respiratory disease (BRD) and the control of BRD in beef and
non-lactating dairy cattle at high risk of developing BRD. Has bactericidal activity against the major bovine pathogens Mannheimia
haemolytica, Pasteurella multocida, Histophilus somni and Mycoplasma bovis. Kills 97% of BRD-causing bacteria in 1-2 hours. Reaches
therapeutic drug concentrations at the site of infection in the lung in 1-2 hours. Administered as a single-dose therapy for BRD
and swine respiratory disease (SRD).
antimicrobial agent. FDA approved for the treatment of bovine respiratory disease (BRD) and the control of BRD in beef and
non-lactating dairy cattle at high risk of developing BRD. Has bactericidal activity against the major bovine pathogens Mannheimia
haemolytica, Pasteurella multocida, Histophilus somni and Mycoplasma bovis. Kills 97% of BRD-causing bacteria in 1-2 hours. Reaches
therapeutic drug concentrations at the site of infection in the lung in 1-2 hours. Administered as a single-dose therapy for BRD
and swine respiratory disease (SRD).
- (Loading SDS PDF) SDS Sheet